| scholarly article | Q13442814 |
| P356 | DOI | 10.1039/D1SC04471K |
| P50 | author | Fabien Plisson | Q63968136 |
| P2093 | author name string | F. I. Saldívar-González | |
| J. L. Medina-Franco | |||
| V. D. Aldas-Bulos | |||
| P2860 | cites work | InChI, the IUPAC International Chemical Identifier | Q21146620 |
| The HHpred interactive server for protein homology detection and structure prediction | Q24530456 | ||
| A robotic platform for flow synthesis of organic compounds informed by AI planning | Q67654159 | ||
| Isolation and structure of harzianum A: a new trichothecene from Trichoderma harzianum | Q72503951 | ||
| The role of natural products in a modern drug discovery program | Q73396825 | ||
| Performance of similarity measures in 2D fragment-based similarity searching: comparison of structural descriptors and similarity coefficients | Q78552727 | ||
| Chemical space and biology | Q81153866 | ||
| CDRUG: a web server for predicting anticancer activity of chemical compounds | Q85227113 | ||
| Patenting natural products just got harder | Q87840647 | ||
| Scaffold hopping | Q88189333 | ||
| Statistical Investigation into the Structural Complementarity of Natural Products and Synthetic Compounds | Q88520831 | ||
| Novel potential agents for ulcerative colitis by molecular topology: suppression of IL-6 production in Caco-2 and RAW 264.7 cell lines. | Q46222499 | ||
| The influence of drug-like concepts on decision-making in medicinal chemistry | Q46922861 | ||
| In silico toxicity profiling of natural product compound libraries from African flora with anti-malarial and anti-HIV properties | Q47250374 | ||
| Importance of Rigidity in Designing Small Molecule Drugs To Tackle Protein-Protein Interactions (PPIs) through Stabilization of Desired Conformers. | Q47400125 | ||
| Increased diversity of peptidic natural products revealed by modification-tolerant database search of mass spectra. | Q47555721 | ||
| Harnessing the potential of natural products in drug discovery from a cheminformatics vantage point | Q47626065 | ||
| Nature is the best source of anti-inflammatory drugs: indexing natural products for their anti-inflammatory bioactivity. | Q47669014 | ||
| De Novo Design of Bioactive Small Molecules by Artificial Intelligence. | Q47741086 | ||
| Automating drug discovery | Q47780833 | ||
| Recurrent Neural Network Model for Constructive Peptide Design | Q48199204 | ||
| Revealing the macromolecular targets of complex natural products | Q48251327 | ||
| De-orphaning the marine natural product (±)-marinopyrrole A by computational target prediction and biochemical validation. | Q48281767 | ||
| A diversity oriented synthesis of natural product inspired molecular libraries. | Q48626870 | ||
| Escape from flatland: increasing saturation as an approach to improving clinical success. | Q48833163 | ||
| A novel applicability domain technique for mapping predictive reliability across the chemical space of a QSAR: reliability-density neighbourhood. | Q49170393 | ||
| The rise of deep learning in drug discovery. | Q49794212 | ||
| The Chemistry Development Kit (CDK): an open-source Java library for Chemo- and Bioinformatics | Q27061829 | ||
| Why is Tanimoto index an appropriate choice for fingerprint-based similarity calculations? | Q27702310 | ||
| Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking | Q27818844 | ||
| Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings | Q27861111 | ||
| Ligand Fishing: A Remarkable Strategy for Discovering Bioactive Compounds from Complex Mixture of Natural Products | Q28078597 | ||
| SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules | Q28090714 | ||
| Target-oriented and diversity-oriented organic synthesis in drug discovery | Q28138837 | ||
| The evolving role of natural products in drug discovery | Q28236671 | ||
| A shape-based 3-D scaffold hopping method and its application to a bacterial protein-protein interaction | Q28237717 | ||
| Analysis of biological processes and diseases using text mining approaches | Q28266447 | ||
| Evolution of polyketide synthases in bacteria | Q28267392 | ||
| Text-mining solutions for biomedical research: enabling integrative biology | Q28465613 | ||
| Understanding and classifying metabolite space and metabolite-likeness | Q28478426 | ||
| DOGS: reaction-driven de novo design of bioactive compounds | Q28480868 | ||
| ZINC 15--Ligand Discovery for Everyone | Q28607096 | ||
| KnowLife: a versatile approach for constructing a large knowledge graph for biomedical sciences | Q28646868 | ||
| Best Practices for QSAR Model Development, Validation, and Exploitation | Q28649930 | ||
| Open-source platform to benchmark fingerprints for ligand-based virtual screening | Q28681290 | ||
| Natural product-likeness score revisited: an open-source, open-data implementation | Q28727975 | ||
| Global mapping of pharmacological space | Q29615876 | ||
| Extended-connectivity fingerprints | Q29616639 | ||
| Relating protein pharmacology by ligand chemistry | Q29617492 | ||
| What can a chemist learn from nature's macrocycles?--a brief, conceptual view. | Q30320257 | ||
| Charting biologically relevant chemical space: a structural classification of natural products (SCONP) | Q30351855 | ||
| Comparison of topological, shape, and docking methods in virtual screening. | Q30362572 | ||
| Computer-Assisted Synthetic Planning: The End of the Beginning. | Q30386672 | ||
| Bioactivity-guided navigation of chemical space | Q30389362 | ||
| Natural products as starting points for future anti-malarial therapies: going back to our roots? | Q30396384 | ||
| Novel chemical space exploration via natural products | Q30488200 | ||
| Similarity coefficients for binary chemoinformatics data: overview and extended comparison using simulated and real data sets | Q30573872 | ||
| Prediction of 'drug-likeness'. | Q30829130 | ||
| Pursuing the leadlikeness concept in pharmaceutical research. | Q30832332 | ||
| Natural products and combinatorial chemistry: back to the future | Q30832368 | ||
| Libraries from natural product-like scaffolds | Q30832378 | ||
| Computational planning of the synthesis of complex natural products | Q100531000 | ||
| Deep learning enables discovery of highly potent anti-osteoporosis natural products | Q101409139 | ||
| Ethnobotany and the Role of Plant Natural Products in Antibiotic Drug Discovery | Q101464060 | ||
| Fragment Library of Natural Products and Compound Databases for Drug Discovery | Q101561748 | ||
| Computer Assisted Structure Elucidation (CASE): Current and Future Perspectives | Q102071424 | ||
| Cheminformatics to Characterize Pharmacologically Active Natural Products | Q102207843 | ||
| Comprehensive prediction of secondary metabolite structure and biological activity from microbial genome sequences | Q103028703 | ||
| Expansion of RiPP biosynthetic space through integration of pan-genomics and machine learning uncovers a novel class of lantibiotics | Q104558041 | ||
| Informatics for Chemistry, Biology, and Biomedical Sciences | Q104683338 | ||
| COCONUT online: Collection of Open Natural Products database | Q104840023 | ||
| The LOTUS Initiative for Open Natural Products Research: Knowledge Management through Wikidata | Q105742243 | ||
| Visualization of very large high-dimensional data sets as minimum spanning trees | Q106856815 | ||
| One molecular fingerprint to rule them all: drugs, biomolecules, and the metabolome | Q106856841 | ||
| Natural products in drug discovery: advances and opportunities | Q107031219 | ||
| A Machine Learning Bioinformatics Method to Predict Biological Activity from Biosynthetic Gene Clusters | Q108127361 | ||
| DECIMER: towards deep learning for chemical image recognition | Q109228844 | ||
| Integrating genomics and metabolomics for scalable non-ribosomal peptide discovery | Q111858324 | ||
| A Deep Learning-Based Approach for Identifying the Medicinal Uses of Plant-Derived Natural Compounds | Q112063369 | ||
| Learning from Nature: From a Marine Natural Product to Synthetic Cyclooxygenase-1 Inhibitors by Automated De Novo Design | Q112579991 | ||
| Rationality over fashion and hype in drug design | Q113240471 | ||
| Strategies for Database Dereplication of Natural Products | Q114829089 | ||
| Mining genomes to illuminate the specialized chemistry of life | Q114867173 | ||
| Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019 | Q114867582 | ||
| The Design-Build-Test-Learn cycle for metabolic engineering of Streptomycetes | Q114867604 | ||
| MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights | Q114872580 | ||
| The year 2020 in natural product bioinformatics: an overview of the latest tools and databases | Q114873619 | ||
| Algorithmic Discovery of Tactical Combinations for Advanced Organic Syntheses | Q126586462 | ||
| Machine learning: Trends, perspectives, and prospects | Q38549184 | ||
| Identifying compound efficacy targets in phenotypic drug discovery | Q38566362 | ||
| ChemMaps: Towards an approach for visualizing the chemical space based on adaptive satellite compounds. | Q38631409 | ||
| A Computational Method for Unveiling the Target Promiscuity of Pharmacologically Active Compounds | Q38658125 | ||
| druGAN: An Advanced Generative Adversarial Autoencoder Model for de Novo Generation of New Molecules with Desired Molecular Properties in Silico | Q38681438 | ||
| Computational scaffold hopping: cornerstone for the future of drug design? | Q38686087 | ||
| Information Retrieval and Text Mining Technologies for Chemistry. | Q38687421 | ||
| Deep Convolutional Neural Networks for Image Classification: A Comprehensive Review. | Q38733939 | ||
| Natural product modulators of transient receptor potential (TRP) channels as potential anti-cancer agents | Q38738962 | ||
| A new genome-mining tool redefines the lasso peptide biosynthetic landscape. | Q38752386 | ||
| Computational Multitarget Drug Design. | Q38760828 | ||
| Improving Drug Design: An Update on Recent Applications of Efficiency Metrics, Strategies for Replacing Problematic Elements, and Compounds in Nontraditional Drug Space | Q38773975 | ||
| Deorphaning the Macromolecular Targets of the Natural Anticancer Compound Doliculide | Q38823478 | ||
| Counting on natural products for drug design | Q38843130 | ||
| A renaissance of neural networks in drug discovery. | Q38854003 | ||
| The evolution of genome mining in microbes - a review. | Q38858040 | ||
| Deep Learning in Drug Discovery. | Q38918718 | ||
| Natural products for chronic cough: Text mining the East Asian historical literature for future therapeutics | Q39015366 | ||
| Cornerstones of CRISPR-Cas in drug discovery and therapy | Q39051110 | ||
| Exploring Intrinsic Dimensionality of Chemical Spaces for Robust QSAR Model Development: A Comparison of Several Statistical Approaches | Q39417041 | ||
| Opportunities and challenges in phenotypic drug discovery: an industry perspective | Q39420418 | ||
| Distinguishing between natural products and synthetic molecules by descriptor Shannon entropy analysis and binary QSAR calculations | Q39550489 | ||
| Modeling natural anti-inflammatory compounds by molecular topology | Q40362238 | ||
| An automated Genomes-to-Natural Products platform (GNP) for the discovery of modular natural products | Q40494065 | ||
| QSAR-assisted virtual screening of lead-like molecules from marine and microbial natural sources for antitumor and antibiotic drug discovery. | Q41193471 | ||
| Unveiling (-)-Englerin A as a Modulator of L-Type Calcium Channels | Q41226155 | ||
| RiPPMiner: a bioinformatics resource for deciphering chemical structures of RiPPs based on prediction of cleavage and cross-links | Q41511466 | ||
| A 'rule of 0.5' for the metabolite-likeness of approved pharmaceutical drugs | Q41861993 | ||
| Synthesis of many different types of organic small molecules using one automated process. | Q41889002 | ||
| Indexing Natural Products for Their Potential Anti-Diabetic Activity: Filtering and Mapping Discriminative Physicochemical Properties | Q41934499 | ||
| Beyond the Rule of 5: Lessons Learned from AbbVie's Drugs and Compound Collection. | Q41934667 | ||
| A chemoinformatics approach to the discovery of lead-like molecules from marine and microbial sources en route to antitumor and antibiotic drugs. | Q42003848 | ||
| Ligand-based virtual screening and inductive learning for identification of SIRT1 inhibitors in natural products | Q42041049 | ||
| Scaffold Hunter: a comprehensive visual analytics framework for drug discovery. | Q42695364 | ||
| Antimalarial activity of physalins B, D, F, and G. | Q42726529 | ||
| Molecular de-novo design through deep reinforcement learning | Q42766915 | ||
| Comparative analysis of chemical similarity methods for modular natural products with a hypothetical structure enumeration algorithm | Q42840256 | ||
| From machine learning to natural product derivatives that selectively activate transcription factor PPARgamma | Q43204326 | ||
| The systematic assessment of traditional evidence from the premodern Chinese medical literature: a text-mining approach | Q43448356 | ||
| Text mining and visualisation of Protein-Protein Interactions | Q44989198 | ||
| X-ray analysis on the nanogram to microgram scale using porous complexes | Q45189113 | ||
| Nature is the best source of anticancer drugs: Indexing natural products for their anticancer bioactivity. | Q45795167 | ||
| Generative Recurrent Networks for De Novo Drug Design. | Q45944255 | ||
| In silico modeling on ADME properties of natural products: Classification models for blood-brain barrier permeability, its application to traditional Chinese medicine and in vitro experimental validation. | Q45947032 | ||
| Assessing the impact of generative AI on medicinal chemistry | Q89455397 | ||
| Principle and design of pseudo-natural products | Q89518885 | ||
| Exploring chemical space using natural language processing methodologies for drug discovery | Q89576074 | ||
| A Convolutional Neural Network-Based Approach for the Rapid Annotation of Molecularly Diverse Natural Products | Q89654650 | ||
| Current status of retention time prediction in metabolite identification | Q90124376 | ||
| NeuRiPP: Neural network identification of RiPP precursor peptides | Q90134530 | ||
| Reaching for the bright StARs in chemical space | Q90308262 | ||
| STarFish: A Stacked Ensemble Target Fishing Approach and its Application to Natural Products | Q90559172 | ||
| Chemometrics: a complementary tool to guide the isolation of pharmacologically active natural products | Q90631027 | ||
| Random forest-based imputation outperforms other methods for imputing LC-MS metabolomics data: a comparative study | Q90634614 | ||
| A Toolbox for the Identification of Modes of Action of Natural Products | Q90762608 | ||
| QBMG: quasi-biogenic molecule generator with deep recurrent neural network | Q91103722 | ||
| A Bayesian machine learning approach for drug target identification using diverse data types | Q91344512 | ||
| Two Decades under the Influence of the Rule of Five and the Changing Properties of Approved Oral Drugs | Q91426516 | ||
| Current computational methods for predicting protein interactions of natural products | Q91428220 | ||
| Unsupervised word embeddings capture latent knowledge from materials science literature | Q91595456 | ||
| A Review of the Microbial Production of Bioactive Natural Products and Biologics | Q91687884 | ||
| Rethinking drug design in the artificial intelligence era | Q91698273 | ||
| Targeting Bacterial Genomes for Natural Product Discovery | Q91851735 | ||
| Innovative omics-based approaches for prioritisation and targeted isolation of natural products - new strategies for drug discovery | Q91903041 | ||
| A Fragment Library of Natural Products and its Comparative Chemoinformatic Characterization | Q92017254 | ||
| Dissecting celastrol with machine learning to unveil dark pharmacology | Q92025784 | ||
| Computationally-assisted discovery and structure elucidation of natural products | Q92060433 | ||
| DeepRiPP integrates multiomics data to automate discovery of novel ribosomally synthesized natural products | Q92217266 | ||
| Using deep learning to evaluate peaks in chromatographic data | Q92256165 | ||
| Exploring Chemical Space with Machine Learning | Q92294719 | ||
| Deep learning in drug discovery: opportunities, challenges and future prospects | Q92386364 | ||
| Graph convolutional networks for computational drug development and discovery | Q92473128 | ||
| NaPLeS: a natural products likeness scorer-web application and database | Q92535760 | ||
| A deep learning genome-mining strategy for biosynthetic gene cluster prediction | Q92537968 | ||
| Design of Natural-Product-Inspired Multitarget Ligands by Machine Learning | Q93024397 | ||
| Deep learning enables rapid identification of potent DDR1 kinase inhibitors | Q93065084 | ||
| A general strategy for diversifying complex natural products to polycyclic scaffolds with medium-sized rings | Q93133678 | ||
| The role of computer-assisted structure elucidation (CASE) programs in the structure elucidation of complex natural products | Q93151618 | ||
| Development of Natural Compound Molecular Fingerprint (NC-MFP) with the Dictionary of Natural Products (DNP) for natural product-based drug development | Q94327081 | ||
| QSAR without borders | Q94477921 | ||
| Pseudo-natural products and natural product-inspired methods in chemical biology and drug discovery | Q94500572 | ||
| Scope of 3D Shape-Based Approaches in Predicting the Macromolecular Targets of Structurally Complex Small Molecules Including Natural Products and Macrocyclic Ligands | Q94529670 | ||
| Chinese Herbal Medicines for Rheumatoid Arthritis: Text-Mining the Classical Literature for Potentially Effective Natural Products | Q94959770 | ||
| Artificial intelligence in chemistry and drug design | Q95938036 | ||
| Machine Learning Applications for Mass Spectrometry-Based Metabolomics | Q96429273 | ||
| Cheminformatics in Natural Product-Based Drug Discovery | Q98161215 | ||
| RRE-Finder: a Genome-Mining Tool for Class-Independent RiPP Discovery | Q98890354 | ||
| MicroED in natural product and small molecule research | Q99558675 | ||
| Text mining for modeling of protein complexes enhanced by machine learning | Q99603732 | ||
| Machine learning approaches for elucidating the biological effects of natural products | Q99638623 | ||
| Assigning the Origin of Microbial Natural Products by Chemical Space Map and Machine Learning | Q100393010 | ||
| A machine-learning-based method for prediction of macrocyclization patterns of polyketides and nonribosomal peptides | Q100429850 | ||
| Machine learning-guided discovery and design of non-hemolytic peptides | Q100464810 | ||
| An overview of MetaMap: historical perspective and recent advances | Q34372056 | ||
| Protein-protein interaction predictions using text mining methods | Q34450771 | ||
| The re-emergence of natural products for drug discovery in the genomics era. | Q34459318 | ||
| Text Mining for Protein Docking | Q34504588 | ||
| Why are secondary metabolites (natural products) biosynthesized? | Q34516683 | ||
| A ring-distortion strategy to construct stereochemically complex and structurally diverse compounds from natural products. | Q34592072 | ||
| Modeling anti-allergic natural compounds by molecular topology | Q34677106 | ||
| pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures. | Q35599192 | ||
| Progress in visual representations of chemical space. | Q35669755 | ||
| Natural product discovery: past, present, and future | Q35887454 | ||
| The use of isolated natural products as scaffolds for the generation of chemically diverse screening libraries for drug discovery | Q35887644 | ||
| Classification of scaffold-hopping approaches | Q35893996 | ||
| De Novo Design at the Edge of Chaos | Q35924943 | ||
| Lessons from natural molecules | Q35986033 | ||
| Prediction of compound-target interactions of natural products using large-scale drug and protein information. | Q36094756 | ||
| Searching molecular structure databases with tandem mass spectra using CSI:FingerID. | Q36179301 | ||
| On the evolution of functional secondary metabolites (natural products) | Q36769198 | ||
| In silico identification of anti-cancer compounds and plants from traditional Chinese medicine database. | Q36870882 | ||
| Function-oriented synthesis, step economy, and drug design | Q37045266 | ||
| The exploration of macrocycles for drug discovery--an underexploited structural class | Q37203934 | ||
| Topic modeling for untargeted substructure exploration in metabolomics | Q37473763 | ||
| Molecular networking as a dereplication strategy | Q37606062 | ||
| Identifying the macromolecular targets of de novo-designed chemical entities through self-organizing map consensus | Q37659834 | ||
| Text mining for traditional Chinese medical knowledge discovery: a survey | Q37675271 | ||
| Macrocyclic drugs and clinical candidates: what can medicinal chemists learn from their properties? | Q38138640 | ||
| Design and synthesis of analogues of natural products | Q38398596 | ||
| 'Metabolite-likeness' as a criterion in the design and selection of pharmaceutical drug libraries | Q30854803 | ||
| Function through synthesis-informed design | Q30904733 | ||
| Scaffold architecture and pharmacophoric properties of natural products and trade drugs: application in the design of natural product-based combinatorial libraries | Q30989136 | ||
| Improving the hit-to-lead process: data-driven assessment of drug-like and lead-like screening hits | Q31034164 | ||
| Data visualization during the early stages of drug discovery | Q31049470 | ||
| Visual Analysis of Biological Activity Data with Scaffold Hunter | Q31119028 | ||
| A comparison of physiochemical property profiles of development and marketed oral drugs | Q31135600 | ||
| From protein domains to drug candidates-natural products as guiding principles in the design and synthesis of compound libraries | Q33184231 | ||
| Advancing chemistry and biology through diversity-oriented synthesis of natural product-like libraries | Q33216557 | ||
| Diversity-oriented synthesis: exploring the intersections between chemistry and biology | Q33231454 | ||
| Assessing the scaffold diversity of screening libraries | Q33237551 | ||
| ChemGPS-NP: tuned for navigation in biologically relevant chemical space | Q33282287 | ||
| Synthesis of flavonoid analogues as scaffolds for natural product-based combinatorial libraries | Q33284031 | ||
| Developing a drug-like natural product library | Q33318687 | ||
| Scaffold diversity of natural products: inspiration for combinatorial library design | Q33372355 | ||
| Quantifying biogenic bias in screening libraries | Q33456687 | ||
| Bioactivity-guided mapping and navigation of chemical space. | Q33475595 | ||
| Interactive exploration of chemical space with Scaffold Hunter | Q33475598 | ||
| Multi-targeted natural products evaluation based on biological activity prediction with PASS. | Q33539970 | ||
| Targeting protein kinases in central nervous system disorders | Q33671660 | ||
| Diversity-oriented synthesis as a tool for the discovery of novel biologically active small molecules | Q33702000 | ||
| Drug repositioning for enzyme modulator based on human metabolite-likeness | Q33802239 | ||
| Natural product-like virtual libraries: recursive atom-based enumeration | Q33841317 | ||
| Exploring and exploiting biologically relevant chemical space | Q33895726 | ||
| Molecular properties that influence the oral bioavailability of drug candidates | Q34130727 | ||
| Nonlinear dimensionality reduction and mapping of compound libraries for drug discovery | Q34156744 | ||
| Reoptimization of MDL keys for use in drug discovery | Q34160151 | ||
| Property distributions: differences between drugs, natural products, and molecules from combinatorial chemistry | Q34172646 | ||
| Nonleadlikeness and leadlikeness in biochemical screening | Q34174693 | ||
| Charting, navigating, and populating natural product chemical space for drug discovery | Q34248306 | ||
| A minimalist fragment approach for the design of natural-product-like synthetic scaffolds | Q34289948 | ||
| Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature | Q34312732 | ||
| Molecular scaffold analysis of natural products databases in the public domain | Q34365901 | ||
| Performance evaluation of 2D fingerprint and 3D shape similarity methods in virtual screening. | Q50497742 | ||
| Chemography of natural product space. | Q50954598 | ||
| Natural product-likeness score and its application for prioritization of compound libraries. | Q51899910 | ||
| y-Randomization and its variants in QSPR/QSAR. | Q51905625 | ||
| Evaluating virtual screening methods: good and bad metrics for the "early recognition" problem. | Q51922697 | ||
| Characteristic physical properties and structural fragments of marketed oral drugs. | Q52005766 | ||
| Computer prediction of possible toxic action from chemical structure: an update on the DEREK system. | Q52312915 | ||
| Automatic Chemical Design Using a Data-Driven Continuous Representation of Molecules. | Q52659131 | ||
| Identification of Estrogen Receptor α Antagonists from Natural Products via In Vitro and In Silico Approaches. | Q55207272 | ||
| Comparison of Shape-Matching and Docking as Virtual Screening Tools | Q56853909 | ||
| Implications of endogenous roles of transporters for drug discovery: hitchhiking and metabolite-likeness | Q56974219 | ||
| Comparing the chemical spaces of metabolites and available chemicals: models of metabolite-likeness | Q56977822 | ||
| Molecular Descriptors for Chemoinformatics | Q56978888 | ||
| Computational Methodologies in the Exploration of Marine Natural Product Leads | Q57001336 | ||
| Chromopynones are pseudo natural product glucose uptake inhibitors targeting glucose transporters GLUT-1 and -3 | Q57006537 | ||
| PASS: prediction of activity spectra for biologically active substances | Q57009681 | ||
| Organic structure determination using atomic-resolution scanning probe microscopy | Q57185527 | ||
| Novelty in the target landscape of the pharmaceutical industry | Q57338670 | ||
| Machine intelligence decrypts β-lapachone as an allosteric 5-lipoxygenase inhibitor | Q57496141 | ||
| Dereplication strategies in natural product research: How many tools and methodologies behind the same concept? | Q57817576 | ||
| Indexing natural products for their antifungal activity by filters-based approach: Disclosure of discriminative properties | Q58552344 | ||
| A Brief Overview of Two Major Strategies in Diversity-Oriented Synthesis: Build/Couple/Pair and Ring-Distortion | Q58580325 | ||
| Impact of Molecular Descriptors on Computational Models | Q58582134 | ||
| Tuning artificial intelligence on the de novo design of natural-product-inspired retinoid X receptor modulators | Q58880965 | ||
| Predictive classifier models built from natural products with antimalarial bioactivity using machine learning approach | Q59126454 | ||
| Computer-Assisted Design of Complex Organic Syntheses | Q61779901 | ||
| A Computer-Driven Approach to Discover Natural Product Leads for Methicillin-Resistant Infection Therapy | Q61812090 | ||
| Natural product derived privileged scaffolds in drug discovery | Q62223687 | ||
| Inverse molecular design using machine learning: Generative models for matter engineering | Q62495185 | ||
| From Complex Natural Products to Simple Synthetic Mimetics by Computational De Novo Design | Q62608586 | ||
| Computer-Assisted Discovery of Retinoid X Receptor Modulating Natural Products and Isofunctional Mimetics | Q62618292 | ||
| Comprehensive and Empirical Evaluation of Machine Learning Algorithms for Small Molecule LC Retention Time Prediction | Q62703800 | ||
| Characterization of the Chemical Space of Known and Readily Obtainable Natural Products | Q62761938 | ||
| NP-Scout: Machine Learning Approach for the Quantification and Visualization of the Natural Product-Likeness of Small Molecules | Q62763486 | ||
| SIRIUS 4: a rapid tool for turning tandem mass spectra into metabolite structure information | Q63352058 | ||
| Applications of machine learning in drug discovery and development. | Q63979755 | ||
| Informatics and Computational Methods in Natural Product Drug Discovery: A Review and Perspectives | Q64078667 | ||
| Predicting Blood⁻Brain Barrier Permeability of Marine-Derived Kinase Inhibitors Using Ensemble Classifiers Reveals Potential Hits for Neurodegenerative Disorders | Q64251797 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | artificial intelligence | Q11660 |
| natural product | Q901227 | ||
| drug discovery | Q1418791 | ||
| P577 | publication date | 2021-12-13 | |
| P1433 | published in | Chemical Science | Q2962267 |
| P1476 | title | Natural product drug discovery in the artificial intelligence era |
| Q114020979 | Commentary: Unexpected Novel Chemical Weapon Agents Designed by Innocuous Drug-Development AI (Artificial Intelligence) Algorithm |
| Q114147556 | A brief guide to machine learning for antibiotic discovery |
| Q123351283 | Artifical intelligence: a virtual chemist for natural product drug discovery |
| Q125446742 | Artificial Intelligence and Discovery of Microbial Natural Products |
| Q115889077 | Chemoinformatics and artificial intelligence colloquium: progress and challenges in developing bioactive compounds |
| Q125386390 | Exploring Diverse Bioactive Secondary Metabolites from Marine Microorganisms Using Co-Culture Strategy |
| Q117043683 | Open data and algorithms for open science in AI-driven molecular informatics |
| Q115190131 | Ring systems in natural products: structural diversity, physicochemical properties, and coverage by synthetic compounds |
| Q125766030 | Therapeutic Potential of Bioactive Flavonoids from Citrus Fruit Peels toward Obesity and Diabetes Mellitus |
| Q114868676 | Updated Trends on the Biodiscovery of New Marine Natural Products from Invertebrates |
| Q120037169 | Yin-yang in drug discovery: rethinking de novo design and development of predictive models |
Search more.